Fifth Third Bancorp Organogenesis Holdings Inc. Transaction History

Fifth Third Bancorp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$3.14 - $6.43 $1,943 - $3,980	619 New	619 $2,000
Q2 2022 Aug 04, 2022	SELL	$4.74 - $8.15 $2,294 - $3,944	-484 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$6.47 - $9.57 $3,131 - $4,631	484 New	484 $4,000
Q4 2021 Feb 01, 2022	SELL	$9.02 - $13.5 $1,199 - $1,795	-133 Closed	0 $0
Q3 2021 Oct 15, 2021	BUY	$13.71 - $17.18 $1,823 - $2,284	133 New	133 $2,000

118

64.3M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $462M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.